Lunai Bioworks
Why Robinhood?
You can watch Lunai Bioworks and buy or sell other stocks, ETFs, and their options commission-free!About RENB
Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21.
RENB Key Statistics
Stock Snapshot
As of today, Lunai Bioworks(RENB) shares are valued at $1.42. The company's market cap stands at 34.35M, with a P/E ratio of -0.02.
On 2026-03-14, Lunai Bioworks(RENB) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Lunai Bioworks(RENB) stock has reached 0, versus its average volume of 3.38M.
The stock's 52-week range extends from a low of $0.15 to a high of $8.02.
The stock's 52-week range extends from a low of $0.15 to a high of $8.02.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.